These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15491144)

  • 21. Vinaxanthone, a new FabI inhibitor from Penicillium sp.
    Zheng CJ; Sohn MJ; Kim WG
    J Antimicrob Chemother; 2009 May; 63(5):949-53. PubMed ID: 19282328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.
    Yogiara ; Mordukhova EA; Kim D; Kim WG; Hwang JK; Pan JG
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127651. PubMed ID: 33130290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
    Roth TA; Minasov G; Morandi S; Prati F; Shoichet BK
    Biochemistry; 2003 Dec; 42(49):14483-91. PubMed ID: 14661960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
    Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
    J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional expression of Francisella tularensis FabH and FabI, potential antibacterial targets.
    Wen L; Chmielowski JN; Bohn KC; Huang JK; Timsina YN; Kodali P; Pathak AK
    Protein Expr Purif; 2009 May; 65(1):83-91. PubMed ID: 19095065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
    Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
    J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.
    Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K
    Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signature gene expression profile of triclosan-resistant Escherichia coli.
    Yu BJ; Kim JA; Pan JG
    J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
    Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
    J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the beta-carbon processing reactions of the mammalian cytosolic fatty acid synthase: role of the central core.
    Witkowski A; Joshi AK; Smith S
    Biochemistry; 2004 Aug; 43(32):10458-66. PubMed ID: 15301544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of pyridine nucleotide substrates with Escherichia coli dihydrodipicolinate reductase: thermodynamic and structural analysis of binary complexes.
    Reddy SG; Scapin G; Blanchard JS
    Biochemistry; 1996 Oct; 35(41):13294-302. PubMed ID: 8873595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallographic analysis of triclosan bound to enoyl reductase.
    Roujeinikova A; Levy CW; Rowsell S; Sedelnikova S; Baker PJ; Minshull CA; Mistry A; Colls JG; Camble R; Stuitje AR; Slabas AR; Rafferty JB; Pauptit RA; Viner R; Rice DW
    J Mol Biol; 1999 Nov; 294(2):527-35. PubMed ID: 10610777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamics of aminoglycoside binding to aminoglycoside-3'-phosphotransferase IIIa studied by isothermal titration calorimetry.
    Ozen C; Serpersu EH
    Biochemistry; 2004 Nov; 43(46):14667-75. PubMed ID: 15544337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus.
    Ji Y; Yin D; Fox B; Holmes DJ; Payne D; Rosenberg M
    FEMS Microbiol Lett; 2004 Feb; 231(2):177-84. PubMed ID: 14987762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).
    Sampson PB; Picard C; Handerson S; McGrath TE; Domagala M; Leeson A; Romanov V; Awrey DE; Thambipillai D; Bardouniotis E; Kaplan N; Berman JM; Pauls HW
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5355-8. PubMed ID: 19682901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamics of a protein acylation: activation of Escherichia coli hemolysin toxin.
    Worsham LM; Langston KG; Ernst-Fonberg ML
    Biochemistry; 2005 Feb; 44(4):1329-37. PubMed ID: 15667226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
    Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
    J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.